Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Combined application of Er:YAG and Nd:YAG lasers in treatment of chronic periodontitis. A split-mouth, single-blind, randomized controlled trial.

Sağlam M, Köseoğlu S, Taşdemir I, Erbak Yılmaz H, Savran L, Sütçü R.

J Periodontal Res. 2017 Oct;52(5):853-862. doi: 10.1111/jre.12454. Epub 2017 Mar 23.

PMID:
28332191
2.

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.

Mangrud OM, Gudlaugsson E, Skaland I, Tasdemir I, Dalen I, van Diermen B, Baak JP, Janssen EA.

Hum Pathol. 2014 Jul;45(7):1496-503. doi: 10.1016/j.humpath.2014.03.001. Epub 2014 Mar 26.

PMID:
24796506
3.

Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.

Mangrud OM, Waalen R, Gudlaugsson E, Dalen I, Tasdemir I, Janssen EA, Baak JP.

PLoS One. 2014 Jan 7;9(1):e83192. doi: 10.1371/journal.pone.0083192. eCollection 2014.

4.

5-Year outcome of a randomized prospective study comparing bacillus Calmette-Guérin with epirubicin and interferon-α2b in patients with T1 bladder cancer.

Hemdan T, Johansson R, Jahnson S, Hellström P, Tasdemir I, Malmström PU; Members of the Urothelial Cancer Group of the Nordic Association of Urology.

J Urol. 2014 May;191(5):1244-9. doi: 10.1016/j.juro.2013.11.005. Epub 2013 Nov 11.

PMID:
24231843
5.

Oncological outcome in patients treated for rectal carcinoma and followed up for 20 years was associated with local recurrence and a new primary cancer.

Søndenaa K, Tasdemir I, Nesvik I, Undheim SO, Bru T, Vetrhus M, Eide GE.

Colorectal Dis. 2012 May;14(5):643-4. doi: 10.1111/j.1463-1318.2012.02950.x. No abstract available.

PMID:
22260150
6.

Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.

Solberg A, Widmark A, Tasdemir I, Ahlgren G, Angelsen A.

Scand J Urol Nephrol. 2011 Sep;45(4):233-8. doi: 10.3109/00365599.2011.560577. Epub 2011 Mar 31.

PMID:
21452932
7.

Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial.

Solberg A, Haugen OA, Viset T, Bergh A, Tasdemir I, Ahlgren G, Widmark A, Angelsen A.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):55-61. doi: 10.1016/j.ijrobp.2010.01.072.

PMID:
20598453
8.

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3.

Lancet. 2009 Jan 24;373(9660):301-8. doi: 10.1016/S0140-6736(08)61815-2. Epub 2008 Dec 16. Erratum in: Lancet. 2009 Apr 4;373(9670):1174.

9.

Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years.

Iversen P, Johansson JE, Lodding P, Kylmälä T, Lundmo P, Klarskov P, Tammela TL, Tasdemir I, Morris T, Armstrong J; Scandinavian Prostate Cancer Group.

Scand J Urol Nephrol. 2006;40(6):441-52.

PMID:
17130095
10.

Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6.

Iversen P, Johansson JE, Lodding P, Lukkarinen O, Lundmo P, Klarskov P, Tammela TL, Tasdemir I, Morris T, Carroll K; Scandinavian Prostatic Cancer Group.

J Urol. 2004 Nov;172(5 Pt 1):1871-6.

PMID:
15540741
11.

[Experiences with ritual circumcision in Norway].

Vaage S, Tasdemir I, Maehlum O.

Tidsskr Nor Laegeforen. 2002 Jan 10;122(1):59-61. Norwegian.

12.

Effect of pentoxifylline on immotile testicular spermatozoa.

Taşdemir I, Taşdemir M, Tavukçuoğlu S.

J Assist Reprod Genet. 1998 Feb;15(2):90-2.

13.

Effect of abnormal sperm head morphology on the outcome of intracytoplasmic sperm injection in humans.

Taşdemir I, Taşdemir M, Tavukçuoglu S, Kahraman S, Biberoģlu K.

Hum Reprod. 1997 Jun;12(6):1214-7.

PMID:
9222003
14.

Endometrium is not a reservoir for recurrent vaginal candidiasis.

Taşdemir M, Taşdemir I, Taşdemir S, Tavukçuoğlu S.

Clin Exp Obstet Gynecol. 1997;24(2):112-3.

PMID:
9342480
15.

Changing epidemiology of measles in Turkey: need for reassessment of measles vaccination policy?

Egemen A, Taşdemir I, Eker L, Arcasoy M.

J Trop Pediatr. 1996 Oct;42(5):299-301. doi: 10.1093/tropej/42.5.299.

PMID:
8936963
16.

Pregnancies achieved with testicular and ejaculated spermatozoa in combination with intracytoplasmic sperm injection in men with totally or initially immotile spermatozoa in the ejaculate.

Kahraman S, Tasdemir M, Tasdemir I, Vicdan K, Ozgur S, Polat G, Islk AZ, Biberoğlu K, Vanderzwalmen P, Nijs M, Schoysman R.

Hum Reprod. 1996 Jun;11(6):1343-6.

PMID:
8671452
17.

Sperm immobilization antibodies in infertile male sera decrease the acrosome reaction: a possible mechanism for immunologic infertility.

Taşdemir I, Taşdemir M, Fukuda J, Kodama H, Matsui T, Tanaka T.

J Assist Reprod Genet. 1996 May;13(5):413-6.

PMID:
8739058
18.

Fertility with testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermic men.

Kahraman S, Ozgür S, Alataş C, Aksoy S, Taşdemir M, Nuhoğlu A, Taşdemir I, Balaban B, Biberoğlu K, Schoysman R, Nijs M, Vanderzwalmen P.

Hum Reprod. 1996 Apr;11(4):756-60.

PMID:
8671323
19.

Short protocol of gonadotropin releasing hormone agonist administration gave better results in long protocol poor-responders in IVF-ET.

Taşdemir M, Taşdemir I, Kodama H, Fukuda J, Tanaka T.

J Obstet Gynaecol Res. 1996 Feb;22(1):73-7.

PMID:
8624897
20.

Alternative treatment for bacterial vaginosis in pregnant patients; restoration of vaginal acidity and flora.

Tasdemir M, Tasdemir I, Tasdemir S, Tavukcuoglu S.

Arch AIDS Res. 1996;10(4):239-41.

PMID:
12347751

Supplemental Content

Loading ...
Support Center